Ph.D. Michael Exton - 28 Feb 2026 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Exton, Ph.D.
Issuer symbol
LXRX
Transactions as of
28 Feb 2026
Net transactions value
-$301,102
Form type
4
Filing time
03 Mar 2026, 07:15:34 UTC
Previous filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Ph.D. Michael Exton filed Form 4 for LEXICON PHARMACEUTICALS, INC. (LXRX) on 03 Mar 2026."

Quick Takeaways

  • This page summarizes Ph.D. Michael Exton's Form 4 filing for LEXICON PHARMACEUTICALS, INC. (LXRX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 03 Mar 2026, 07:15.

What Changed

  • Previous filing in this sequence was filed on 17 Feb 2026.
  • Current net transaction value: -$301,102.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Exton Michael Chief Executive Officer, Director 2445 TECHNOLOGY FOREST BLVD, 11TH FLOOR, THE WOODLANDS /s/ Michael Exton, Ph.D. 03 Mar 2026 0002029249

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +503,263 503,263 28 Feb 2026 Direct F1
transaction LXRX Common Stock Tax liability $301,102 -204,831 -41% $1.47 298,432 28 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -503,263 -33% 1,006,527 28 Feb 2026 Common Stock 503,263 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Sponsored